Magenta Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch MGTA and buy or sell other stocks, ETFs, and their options commission-free!About MGTA
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies.
CEOMarino Garcia, MBA
CEOMarino Garcia, MBA
Employees78
Employees78
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2015
Founded2015
Employees78
Employees78
MGTA Key Statistics
Market cap513.83M
Market cap513.83M
Price-Earnings ratio-10.91
Price-Earnings ratio-10.91
Dividend yield—
Dividend yield—
Average volume520.66K
Average volume520.66K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$45.46
52 Week high$45.46
52 Week low$13.37
52 Week low$13.37
Stock Snapshot
With a market cap of 513.83M, Magenta Therapeutics(MGTA) trades at $11.99. The stock has a price-to-earnings ratio of -10.91.
During the trading day, Magenta Therapeutics(MGTA) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Magenta Therapeutics(MGTA) stock has reached 0, versus its average volume of 520.66K.
Over the past 52 weeks, Magenta Therapeutics(MGTA) stock has traded between a high of $45.46 and a low of $13.37.
Over the past 52 weeks, Magenta Therapeutics(MGTA) stock has traded between a high of $45.46 and a low of $13.37.
People also own
Based on the portfolios of people who own MGTA. This list is generated using Robinhood data, and it’s not a recommendation.